Industry Experts

Chris Mulhern is the Head of Machine Learning and Data Science Computation at Orogen Therapeutics, bringing nearly a decade of small molecule discovery experience. He was previously with X-Chem Pharmaceuticals and continued into ML for the small molecule discovery spin-out ZebiAI, which was acquired by Relay Therapeutics. He continued to Terray Therapeutics before joining Animol Discovery where he headed the informatics and ML functions, before joining Orogen.
Through these experiences he has played a part in more than 200 DEL campaigns, and implemented a variety of cheminformatics, machine learning, and computational chemistry tools to aid in the discovery and h2l processes. Chris received his bachelor's degree from Trinity College, Hartford, CT.